Pharmacists in Pageland, SC Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Mr. Christopher Sullivan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 S Van L Mungo Blvd, Pageland, SC 29728 Phone: 843-675-2323 Fax: 843-675-2025 |
 Debra Blackwell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 North Van Lingle Mungo Blvd, Pageland, SC 29728 Phone: 843-672-2420 |
Dr. Ronald Eli Dickerson Jr., PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 North Van Lingle Mungo Blvd, Pageland, SC 29728 Phone: 843-672-2420 |
Dayle Bentley Helms, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 South Van Lingle Mungo Blvd, Pageland, SC 29728 Phone: 843-675-2323 Fax: 843-675-2025 |
News Archive
Moms' tight work schedules may affect their children's sleep
It may be tough for working moms to get a good night's sleep, but working tight hours may affect their children's sleep, too.
‘Hygiene hypothesis' updated to ‘Old Friends' hypothesis
A new scientific report out today from the International Scientific Forum on Home Hygiene (IFH) dismantles the myth that the epidemic rise in allergies in recent years has happened because we're living in sterile homes and overdoing hygiene.
Bacteria's sticky glue is clue to vaccine says scientist
Sticky glue secreted by the bacterium Staphylococcus aureus could be the clue scientists have been searching for to make an effective vaccine against MRSA, medical researchers heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Study: Certain factors may protect against the consequences of bullying
It is well-known that victims of bullying can have higher risks of future health and social problems. However, different victims experience a broad range of responses and some may not suffer at all.
FDA accepts GPC Biotech's Satraplatin NDA
GPC Biotech AG has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer (HRPC) whose prior chemotherapy has failed.
› Verified 2 days ago